Novavax Inc

Healthcare

A biotechnology company Novavax Inc (NASDAQ:NVAX) is into the production of next-generation vaccines for the treatment of serious infectious diseases. The Company has discovered a vaccine candidate for COVID-19 named as NVX-CoV2373 which is a stable, prefusion protein produced by employing the proprietary nanoparticle-based technology of Novavax.

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK